Alveo Technologies news

Alveo Technologies, a leader in developing novel technologies that enable real-time, low-cost, at-home molecular detection of infectious disease, today announced that Fran Soistman has joined the company’s Scientific Advisory Board (SAB). Soistman is an accomplished business executive who has decades of experience driving profitable growt

Alveo Technologies, Inc. (Alveo) announced today that it has been named a winner of the $6M XPRIZE Rapid COVID Testing Competition for its be.well COVID-19 Test. The be.well™ platform provides individuals access to molecular testing and cloud-based analytics for rapid diagnosis and management of infectious diseases.   

The $6 million XPRIZE Rapid

Alveo Technologies, Inc. (Alveo) announced today that it has received its first regulatory approval with the CE (Conformité Européenne) Mark for its be.well COVID-19 Flex Test.  The be.well platform is a molecular test based on an isothermal nucleic acid amplification process, and has a real-time healthcare data application program to help accelerate time to COVID-19 treatment and surveillance. 

“Alveo is pleas

Alveo Technologies, today announced it has been awarded a grant to improve upon the performance and usability of its testing platform, and if successful, to advance the development and scale manufacturing of the company’s be.well™ COVID-19 test from the Bill & Melinda Gates Foundation. As the first of its kind platform, 

Alveo Technologies, a leader in developing novel technologies that enable real-time, low-cost, at-home molecular detection of infectious disease, today announced that Professor Justin Stebbing M.D., Ph.D., has been appointed to its Scientific Advisory Board (SAB). In this role, Professor Ste